Related Experiment Video
Updated: Jul 20, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G
Hiroaki Miyahara1, Chisato Tamai1, Masanori Inoue2
1Department of Neuropathology, Institute for Medical Research of Aging, Aichi Medical University, Aichi, Japan.
Abstract:
The mitochondrial (m.) 3243A>G mutation is known to be associated with various mitochondrial diseases including mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Their clinical symptoms have been estimated to occur with an increased mitochondrial DNA (mtDNA) heteroplasmy and reduced activity of oxidative phosphorylation (OXPHOS) complexes, but their trends in the central nervous system remain unknown. Six autopsied mutant cases and three disease control cases without the mutation were enrolled in this study. The mutant cases had a disease duration of 1-27 years. Five of six mutant cases were compatible with MELAS. In the mutant cases, cortical lesions including a laminar necrosis were frequently observed in the parietal, lateral temporal, and occipital lobes; less frequently in the frontal lobe including precentral gyrus; and not at all in the medial temporal lobe. The mtDNA heteroplasmy in brain tissue samples of the mutant cases was strikingly high, ranging from 53.8% to 85.2%. The medial temporal lobe was preserved despite an inhospitable environment having high levels of mtDNA heteroplasmy and lactic acid. OXPHOS complex I was widely decreased in the mutant cases. The swelling of smooth muscle cells in the vessels on the leptomeninges, with immunoreactivity (IR) against mitochondria antibody, and a decreased nuclear/cytoplasmic ratio of choroidal epithelial cells were observed in all mutant cases but in none without the mutation. Common neuropathological findings such as cortical laminar necrosis and basal ganglia calcification were not always observed in the mutant cases. A high level of mtDNA heteroplasmy was observed throughout the brain in spite of heterogeneous cortical lesions. A lack of medial temporal lesion, mitochondrial vasculopathy in vessels on the leptomeninges, and an increased cytoplasmic size of epithelial cells in the choroid plexus could be neuropathological hallmarks helpful in the diagnosis of mitochondrial diseases.
Insights
The mitochondrial 3243A>G mutation causes high mtDNA heteroplasmy and OXPHOS complex I decrease in the brain, leading to varied lesions but sparing the medial temporal lobe. These findings aid in diagnosing mitochondrial diseases.
Area of Science:
- Neurology
- Mitochondrial Biology
- Genetics
Background:
- The mitochondrial 3243A>G mutation is linked to MELAS and other mitochondrial diseases.
- Clinical symptoms correlate with mtDNA heteroplasmy and reduced oxidative phosphorylation (OXPHOS), but central nervous system trends are unclear.
Purpose of the Study:
- To investigate neuropathological changes and mtDNA heteroplasmy distribution in the brain in cases with the mitochondrial 3243A>G mutation.
- To identify potential diagnostic hallmarks for mitochondrial diseases.
Main Methods:
- Autopsy brain tissue analysis from six mutant cases and three controls.
- Quantification of mtDNA heteroplasmy.
- Assessment of OXPHOS complex activity.
- Histopathological examination including immunohistochemistry.
Main Results:
- High mtDNA heteroplasmy (53.8–85.2%) found throughout the brain, with heterogeneous cortical lesions (frequent in parietal, temporal, occipital lobes; rare in frontal; absent in medial temporal).
- Reduced OXPHOS complex I activity observed in mutant cases.
- Mitochondrial vasculopathy in leptomeningeal vessels and altered choroidal epithelial cells noted in all mutant cases.
- Medial temporal lobe spared despite high heteroplasmy and lactic acid.
Conclusions:
- High brain-wide mtDNA heteroplasmy and specific neuropathological features, including medial temporal lobe sparing and mitochondrial vasculopathy, are key indicators for diagnosing mitochondrial diseases.
- Neuropathological findings may not always align with common presentations like cortical laminar necrosis or basal ganglia calcification.
Related Concept Videos
ATP Synthase: Mechanism
Lysosomal Hydrolases

